For more information or confidential assistance
Call 800-306-3180

Jacky Gale

Jacky is a long-time contributor to Injury Lawyer News who believes that education is a powerful tool. She hopes to empower readers with knowledge about the pharmaceutical industry so that they may become their own best advocates.

Parents Contend Zofran Caused Son’s Birth Defects

baby holding onto parent's finger
A number of Zofran lawsuits have been filed against GlaxoSmithKline (GSK) with regard to the drug's side effects on unborn children. One of the most recent cases filed against GSK alleges that the defendant’s wrongful conduct and fraudulent misrepresentation directly resulted in a minor child’s severe heart defects... Read More

Safety Study for Xarelto Under Question by FDA

Since it first hit the market in 2011, millions of Americans have been prescribed Xarelto, a newer generation of blood-thinning drugs touted as an alternative to warfarin (Coumadin). But recently, healthcare experts have been questioning whether the clinical trial that led to the FDA approval... Read More

Announcing the 2015 Disability Scholarship Winner!

Injury Lawyer News was founded with the mission of promoting transparency and facilitating the flow of information. As such, we have long been staunch advocates of higher education. We’re very pleased to take the opportunity to give back to the community by offering the Injury... Read More

Family Members Accuse Fresenius of Dialysis-Related Death

Following the untimely loss of Clarence Arrington, his surviving family members filed a Granuflo lawsuit against Fresenius Medical Care Holdings, Inc. Daniel Lemont Arrington, the plaintiff, claims that the decedent lost his life as a result of the allegedly defective dialysis products manufactured by the defendants. The... Read More

Report: FDA Lacks Sufficient Data Regarding Drug Safety

The U.S. Government Accountability Office (GAO) has released a report to the Subcommittee on Labor, Health, and Human Services of the House of Representatives detailing what it calls “problems with (the FDA’s) postmarket safety data.” The GAO report claims that the FDA “lacks reliable, readily... Read More